Skip to main content

Table 2 The MBC (µg/ml) of ciprofloxacin in free form and nanostructured lipid carriers in the presence or absence of rolipram against MRSA

From: Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice

Formulation

MBC (µg/ml)

Ciprofloxacin in free form

0.98

Ciprofloxacin + rolipram

7.81

Ciprofloxacin in NLCs

0.98‒1.95

Ciprofloxacin + rolipram in NLCs

7.81

  1. Each value represents the mean ± SEM (n = 3)
Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us